Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Mersmann, Jan ^a   Iskandar, Franziska ^a   Latsch, Kathrina ^a   Habeck, Katharina ^a   Sprunck, Vera ^a   Zimmermann, René ^a,b   Schumann, Ralf R ^c   Zacharowski, Kai ^a   Koch, Alexander ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN RECEPTOR; TOLL LIKE RECEPTOR 2; TROPONIN T;

AGED; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; DRUG ANTAGONISM; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; LEUKOCYTE; MALE; MIDDLE AGED; MOUSE; PHYSIOLOGY; REPERFUSION INJURY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; FEMALE; HMGB1 PROTEIN; HUMANS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 2; TROPONIN T;

EID: 84893822693     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/174168     Document Type: Article

References (36)

1. Arslan F., Smeets M. B., O'Neill L. A. J., Keogh B., McGuirk P., Timmers L., Tersteeg C., Hoefer I. E., Doevendans P. A., Pasterkamp G., De Kleijn D. P. V., Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010 121 1 80 90 2-s2.0-74549178528 10.1161/CIRCULATIONAHA.109.880187
2. Ha T., Hu Y., Liu L., Lu C., McMullen J. R., Kelley J., Kao R. L., Williams D. L., Gao X., Li C., TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovascular Research 2010 87 4 694 703 2-s2.0-77955888865 10.1093/cvr/cvq116
3. Mersmann J., Berkels R., Zacharowski P., Tran N., Koch A., Iekushi K., Dimmeler S., Granja T. F., Boehm O., Claycomb W. C., Zacharowski K., Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury. Critical Care Medicine 2010 38 3 903 909 2-s2.0-77249096344 10.1097/CCM. 0b013e3181ce50e6
4. Mersmann J., Koch A., Tran N., Zimmermann R., Granja T. F., Larmann J., Herzog C., Theilmeier G., Bornstein S. R., Kirschning C. J., Zacharowski K., Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion. Critical Care Medicine 2010 38 10 1927 1932 2-s2.0-77957231123 10.1097/CCM.0b013e3181ef455b
5. Mersmann J., Tran N., Latsch K., Habeck K., Iskandar F., Zimmermann R., Zacharowski K., Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient mice. Resuscitation 2012 11 1404 1410 2-s2.0-84859899014 10.1016/j.resuscitation.2012.04.001
6. Müller S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L., Agresti A., Beltrame M., Bianchi M. E., The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. The EMBO Journal 2001 20 16 4337 4340 2-s2.0-0035882102 10.1093/emboj/20.16.4337 (Pubitemid 32772027)
7. Tang D., Kang R., Livesey K. M., Cheh C.-W., Farkas A., Loughran P., Hoppe G., Bianchi M. E., Tracey K. J., Zeh H. J. III, Lotze M. T., Endogenous HMGB1 regulates autophagy. Journal of Cell Biology 2010 190 5 881 892 2-s2.0-77956386515 10.1083/jcb.200911078
8. Scaffidi P., Misteli T., Bianchi M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002 418 6894 191 195 2-s2.0-0037062934 10.1038/nature00858 (Pubitemid 34773774)
9. Tang D., Shi Y., Kang R., Li T., Xiao W., Wang H., Xiao X., Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. Journal of Leukocyte Biology 2007 81 3 741 747 2-s2.0-33847775295 10.1189/jlb.0806540 (Pubitemid 46393551)
10. Andersson U., Wang H., Palmblad K., Aveberger A.-C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K. J., High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. Journal of Experimental Medicine 2000 192 4 565 570 2-s2.0-0034698830 10.1084/jem.192.4.565 (Pubitemid 30666257)
11. Wang H., Bloom O., Zhang M., Vishnubhakat J. M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K. R., Faist E., Abraham E., Andersson J., Andersson U., Molina P. E., Abumrad N. N., Sama A., Tracey K. J., HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999 285 5425 248 251 2-s2.0-0033538467 10.1126/science.285.5425.248 (Pubitemid 29329996)
12. Tsan M.-F., Heat shock proteins and high mobility group box 1 protein lack cytokine function. Journal of leukocyte biology 2011 89 6 847 853 2-s2.0-80052800427
13. Andrassy M., Volz H. C., Igwe J. C., Funke B., Eichberger S. N., Kaya Z., Buss S., Autschbach F., Pleger S. T., Lukic I. K., Bea F., Hardt S. E., Humpert P. M., Bianchi M. E., Mairbäurl H., Nawroth P. P., Remppis A., Katus H. A., Bierhaus A., High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008 117 25 3216 3226 2-s2.0-51649111202 10.1161/CIRCULATIONAHA.108.769331
14. Kokkola R., Andersson Å., Mullins G., Östberg T., Treutiger C.-J., Arnold B., Nawroth P., Andersson U., Harris R. A., Harris H. E., RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scandinavian Journal of Immunology 2005 61 1 1 9 2-s2.0-19944431800 10.1111/j.0300-9475.2005.01534.x (Pubitemid 40188342)
15. Taguchi A., Blood D. C., Del Toro G., Canet A., Lee D. C., Qu W., Tanjl N., Lu Y., Lalla E., Fu C., Hofmann M. A., Kislinger T., Ingram M., Lu A., Tanaka H., Hori O., Ogawa S., Stern D. M., Schmidt A. M., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000 405 6784 354 360 2-s2.0-0034682315 10.1038/35012626 (Pubitemid 30337069)
16. Park J. S., Svetkauskaite D., He Q., Kim J.-Y., Strassheim D., Ishizaka A., Abraham E., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. The Journal of Biological Chemistry 2004 279 9 7370 7377 2-s2.0-1542380035 10.1074/jbc.M306793200 (Pubitemid 38294612)
17. Tian J., Avalos A. M., Mao S.-Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L. L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M. K., Fitzgerald K. A., Latz E., Kiener P. A., Coyle A. J., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunology 2007 8 5 487 496 2-s2.0-34247236200 10.1038/ni1457 (Pubitemid 46605917)
18. Jong S. P., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.-Y., Strassheim D., Sohn J.-W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E., High mobility group box 1 protein interacts with multiple Toll-like receptors. American Journal of Physiology: Cell Physiology 2006 290 3 C917 C924 2-s2.0-33645461206 10.1152/ajpcell.00401.2005
19. Yu M., Wang H., Ding A., Golenbock D. T., Latz E., Czura C. J., Fenton M. J., Tracey K. J., Yang H., HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006 26 2 174 179 2-s2.0-33746731651 10.1097/01.shk.0000225404. 51320.82 (Pubitemid 44162504)
20. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Müller S., Pompilio G., Anversa P., Bianchi M. E., Capogrossi M. C., Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circulation research 2005 97 8 e73 83 2-s2.0-32944480771
21. Kitahara T., Takeishi Y., Harada M., Niizeki T., Suzuki S., Sasaki T., Ishino M., Bilim O., Nakajima O., Kubota I., High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovascular Research 2008 80 1 40 46 2-s2.0-51749118759 10.1093/cvr/cvn163
22. Takahashi K., Fukushima S., Yamahara K., Yashiro K., Shintani Y., Coppen S. R., Salem H. K., Brouilette S. W., Yacoub M. H., Suzuki K., Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 2008 14 supplement 1 S106 S114
23. Schröder N. W. J., Hermann C., Hamann L., Göbel U. B., Hartung T., Schumann R. R., High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. Journal of Molecular Medicine 2003 81 6 368 372 2-s2.0-0038466165 (Pubitemid 36783241)
24. Hamann L., Gomma A., Schröder N. W. J., Stamme C., Glaeser C., Schulz S., Gross M., Anker S. D., Fox K., Schumann R. R., A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. Journal of Molecular Medicine 2005 83 6 478 485 2-s2.0-21544462582 10.1007/s00109-005- 0643-7 (Pubitemid 40922170)
25. Mersmann J., Tran N., Zacharowski P. A., Grotemeyer D., Zacharowski K., Rosiglitazone is cardioprotective in a murine model of myocardial i/r. Shock 2008 30 1 64 68 2-s2.0-51549121088 10.1097/SHK.0b013e31815dbdc3
26. Mersmann J., Habeck K., Latsch K., Zimmermann R., Jacoby C., Fischer J. W., Hartmann C., Schrader J., Kirschning C. J., Zacharowski K., Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation. Basic Research in Cardiology 2011 106 1 89 98 2-s2.0-79151476348 10.1007/s00395-010-0127-y
27. Koch A., Hamann L., Schott M., Boehm O., Grotemeyer D., Kurt M., Schwenke C., Schumann R., Bornstein S., Zacharowski K., Genetic variation of TLR4 influences immunoendocrine stress response: an observational study in cardiac surgical patients. Critical Care 2011 2 R109 R109
28. Hamann L., Hamprecht A., Gomma A., Schumann R. R., Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. Journal of Immunological Methods 2004 285 2 281 291 2-s2.0-1242351229 10.1016/j.jim.2003.12.005 (Pubitemid 38224568)
29. Vinten-Johansen J., Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovascular Research 2004 61 3 481 497 2-s2.0-1142309740 10.1016/j.cardiores.2003.10.011 (Pubitemid 38210154)
30. Robert S. M., Sjodin H., Fink M. P., Aneja R. K., Preconditioning with high mobility group Box 1 (HMGB1) induces lipoteichoic acid (LTA) tolerance. Journal of Immunotherapy 2010 33 7 663 671 2-s2.0-77955172640 10.1097/CJI.0b013e3181dcd111
31. Erridge C., Endogenous ligands of TLR2 and TLR4: agonists or assistants? Journal of Leukocyte Biology 2010 87 6 989 999 2-s2.0-77954005130 10.1189/jlb.1209775
32. Youn J. H., Oh Y. J., Kim E. S., Choi J. E., Shin J.-S., High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF- α production in human monocytes. Journal of Immunology 2008 180 7 5067 5074 2-s2.0-44449162626
33. Sha Y., Zmijewski J., Xu Z., Abraham E., HMGB1 develops enhanced proinflammatory activity by binding to cytokines. Journal of Immunology 2008 180 4 2531 2537 2-s2.0-42149192003
34. Hreggvidsdottir H. S., Östberg T., Wähämaa H., Schierbeck H., Aveberger A.-C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H. E., The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. Journal of Leukocyte Biology 2009 86 3 655 662 2-s2.0-70149098507 10.1189/jlb.0908548
35. Sørensen M. V., Pedersen S., Møgelvang R., Skov-Jensen J., Flyvbjerg A., Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction. JACC: Cardiovascular Interventions 2011 4 3 281 286 2-s2.0-79953016177 10.1016/j.jcin.2010.10.015
36. Andrassy M., Volz H. C., Riedle N., Gitsioudis G., Seidel C., Laohachewin D., Zankl A. R., Kaya Z., Bierhaus A., Giannitsis E., Katus H. A., Korosoglou G., HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. Journal of Internal Medicine 2011 270 3 245 253 2-s2.0-80051553550 10.1111/j.1365-2796.2011.02369.x